Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

orgotein

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
PURPOSE To study whether orgotein is effective in preventing late radiation-induced effects. METHODS AND MATERIALS Patients >18… Expand
1996
1996
On the basis of previous experiences indicating that the anti-oxidant agent Cu/Zn superoxide dismutase (SOD) is an effective drug… Expand
1993
1993
  • G. Primus
  • International urology and nephrology
  • 1993
  • Corpus ID: 23515298
Eighteen patients with Peyronie's disease have been treated with the anti-inflammatory metalloprotein Orgotein, which exhibits a… Expand
1989
1989
PURPOSE Superoxide dismutase (orgotein for injection) has been used in managing osteoarthritis for more than seven years in… Expand
1983
1983
The effects of intra-articular injections of orgotein (4 mg a week for six weeks) and of methylprednisolone acetate (4 mg a week… Expand
Highly Cited
1981
Highly Cited
1981
22 patients with Peyronie's disease have been treated with Orgotein, the new anti-inflammatory metalloprotein which pronounced… Expand
Highly Cited
1981
Highly Cited
1981
30 patients with active classical rheumatoid arthritis affecting the knee took part in a 12-week double-blind trial in which… Expand
1981
1981
Twenty-three patients with Peyronie's disease have been treated with the new anti-inflammatory metalloprotein drug orgotein… Expand
Highly Cited
1978
Highly Cited
1978
In rats, daily administration of subcutaneous dose of 2.5 mg/kg of orgotein, the pharmaceutical preparation of Zn-Cu superoxide… Expand
1973
1973
Abstract Orgotein is the generic name for a group of metalloproteins isolatable from many mammalian tissues. Because of their… Expand